ReviewNature metabolism2026
Obesity as a catalyst for neurodegeneration.
Review in Nature metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The parallel rise in obesity and neurological disorders suggests a potential mechanistic link between these two conditions. Midlife obesity is a well-established risk factor for cognitive decline and neurological disorders; however, the underlying mechanisms and cause-and-effect relationship remain poorly defined, in part owing to limited spatiotemporal resolution in existing studies and the absence of a unifying framework. Recent studies have begun to uncover pathways linking obesity to neurodegenerative vulnerability. First, we discuss how obesity induces brain-wide reprogramming across neural, metabolic and vascular systems including neurovascular coupling, blood-brain barrier integrity, cerebrospinal fluid dynamics and myelination. By systematically examining the disparate mechanisms for each condition, a more cohesive picture emerges, revealing progressive neurodegeneration driven by chronic metabolic overload. Lastly, we propose a framework that integrates these different mechanisms with both spatial and temporal specificity.
Indexed as
Identifiers
41760887What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.